In vitro activities of 2,2'-bipyridyl analogs against Mycobacterium leprae.
AUTOR(ES)
Dhople, A M
RESUMO
In vitro susceptibility of Mycobacterium leprae to two bipyridyl analogs was studied by using two biochemical parameters to measure the metabolic activity of the organism. VUF-8514 at 0.16 micrograms/ml, but not VUF-8842, completely inhibited the metabolic activity of M. leprae, and the action was bactericidal. When compared to rifampin (MIC 0.3 micrograms/ml), VUF-8514 was equally bactericidal against M. leprae.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=188306Documentos Relacionados
- Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae.
- In vitro and in vivo activities of macrolides against Mycobacterium leprae.
- In vitro activities of aminoglycosides, lincosamides, and rifamycins against Mycobacterium leprae.
- Mode of action of copper complexes of some 2,2'-bipyridyl analogs on Paracoccus denitrificans.
- In vitro activity of levofloxacin, singly and in combination with rifamycin analogs, against Mycobacterium leprae.
